These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 28194494)

  • 21. A Pilot Study Evaluating the Impact of an Adherence-promoting Intervention Among Nonadherent Youth With Inflammatory Bowel Disease.
    Maddux M; Ricks S; Delurgio S; Hommel K
    J Pediatr Nurs; 2017; 35():72-77. PubMed ID: 28728772
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antiretroviral therapy adherence, medication use, and health care costs during 3 years of a community pharmacy medication therapy management program for Medi-Cal beneficiaries with HIV/AIDS.
    Hirsch JD; Gonzales M; Rosenquist A; Miller TA; Gilmer TP; Best BM
    J Manag Care Pharm; 2011 Apr; 17(3):213-23. PubMed ID: 21434698
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Covert dose reduction is a distinct type of medication non-adherence observed across all care settings in inflammatory bowel disease.
    Mountifield R; Andrews JM; Mikocka-Walus A; Bampton P
    J Crohns Colitis; 2014 Dec; 8(12):1723-9. PubMed ID: 25263934
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inflammatory bowel disease: adherence to immunomodulators in a biological therapy era.
    Campos S; Portela F; Sousa P; Sofia C
    Eur J Gastroenterol Hepatol; 2016 Nov; 28(11):1313-9. PubMed ID: 27501126
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identifying predictors of low adherence in patients with inflammatory bowel disease.
    Coenen S; Weyts E; Ballet V; Noman M; Van Assche G; Vermeire S; Van Emelen J; Ferrante M
    Eur J Gastroenterol Hepatol; 2016 May; 28(5):503-7. PubMed ID: 26760588
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Multidisciplinary Approach to Biopsychosocial Care for Adults With Inflammatory Bowel Disease: A Pilot Study.
    Lee CK; Melmed GY; Mann A; Danovitch I; Hedrick R; McGovern DPB; Targan S; Shih D; Vasiliauskas E; IsHak WW; Feldman E
    Inflamm Bowel Dis; 2018 Nov; 24(12):2550-2554. PubMed ID: 29920581
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Factors that Influence Treatment and Non-treatment Decision Making Among Individuals with Inflammatory Bowel Disease: An Integrative Review.
    Kamp KJ; Brittain K
    Patient; 2018 Jun; 11(3):271-284. PubMed ID: 29313266
    [TBL] [Abstract][Full Text] [Related]  

  • 28. EHealth: self-management in inflammatory bowel disease and in irritable bowel syndrome using novel constant-care web applications. EHealth by constant-care in IBD and IBS.
    Pedersen N
    Dan Med J; 2015 Dec; 62(12):B5168. PubMed ID: 26621403
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gastroenterologists' Views of Shared Decision Making for Patients with Inflammatory Bowel Disease.
    Siegel CA; Lofland JH; Naim A; Gollins J; Walls DM; Rudder LE; Reynolds C
    Dig Dis Sci; 2015 Sep; 60(9):2636-45. PubMed ID: 25939543
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adherence to medical treatment in inflammatory bowel disease patients.
    Zelante A; De Giorgi A; Borgoni R; Trevisani L; Gallerani M
    Minerva Gastroenterol Dietol; 2014 Dec; 60(4):269-74. PubMed ID: 25384805
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transition experience of young adults with inflammatory bowel diseases (IBD): a mixed methods study.
    Plevinsky JM; Gumidyala AP; Fishman LN
    Child Care Health Dev; 2015 Sep; 41(5):755-61. PubMed ID: 25376979
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Beliefs about GI medications and adherence to pharmacotherapy in functional GI disorder outpatients.
    Cassell B; Gyawali CP; Kushnir VM; Gott BM; Nix BD; Sayuk GS
    Am J Gastroenterol; 2015 Oct; 110(10):1382-7. PubMed ID: 25916226
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Review article: medication non-adherence in ulcerative colitis--strategies to improve adherence with mesalazine and other maintenance therapies.
    Hawthorne AB; Rubin G; Ghosh S
    Aliment Pharmacol Ther; 2008 Jun; 27(12):1157-66. PubMed ID: 18384664
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Predictors of medication adherence in inflammatory bowel disease.
    Ediger JP; Walker JR; Graff L; Lix L; Clara I; Rawsthorne P; Rogala L; Miller N; McPhail C; Deering K; Bernstein CN
    Am J Gastroenterol; 2007 Jul; 102(7):1417-26. PubMed ID: 17437505
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development and initial validation of a disease-specific bowel continence questionnaire for inflammatory bowel disease patients: the ICIQ-IBD.
    Dibley L; Norton C; Cotterill N; Bassett P
    Eur J Gastroenterol Hepatol; 2016 Feb; 28(2):233-9. PubMed ID: 26551932
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Health-related quality of life in inflammatory bowel disease: psychosocial, clinical, socioeconomic, and demographic predictors.
    Moradkhani A; Beckman LJ; Tabibian JH
    J Crohns Colitis; 2013 Jul; 7(6):467-73. PubMed ID: 22884758
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Children and young people with inflammatory bowel disease attend less school than their healthy peers.
    Barnes C; Ashton JJ; Borca F; Cullen M; Walker DM; Beattie RM
    Arch Dis Child; 2020 Jul; 105(7):671-676. PubMed ID: 31937567
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Disease-specific knowledge, coping, and adherence in patients with inflammatory bowel disease.
    Moradkhani A; Kerwin L; Dudley-Brown S; Tabibian JH
    Dig Dis Sci; 2011 Oct; 56(10):2972-7. PubMed ID: 21538016
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterisation of complementary and alternative medicine use and its impact on medication adherence in inflammatory bowel disease.
    Weizman AV; Ahn E; Thanabalan R; Leung W; Croitoru K; Silverberg MS; Steinhart AH; Nguyen GC
    Aliment Pharmacol Ther; 2012 Feb; 35(3):342-9. PubMed ID: 22176478
    [TBL] [Abstract][Full Text] [Related]  

  • 40. What are the Unmet Needs and Most Relevant Treatment Outcomes According to Patients with Inflammatory Bowel Disease? A Qualitative Patient Preference Study.
    Schoefs E; Vermeire S; Ferrante M; Sabino J; Lambrechts T; Avedano L; Haaf I; De Rocchis MS; Broggi A; Sajak-Szczerba M; Saldaña R; Janssens R; Huys I
    J Crohns Colitis; 2023 Apr; 17(3):379-388. PubMed ID: 36165579
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.